Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002362445 | SCV002661884 | likely pathogenic | Cardiovascular phenotype | 2023-08-23 | criteria provided, single submitter | clinical testing | The c.69485_69489delTCTAC variant, located in coding exon 174 of the TTN gene, results from a deletion of 5 nucleotides at nucleotide positions 69485 to 69489, causing a translational frameshift with a predicted alternate stop codon (p.L23162Rfs*4). This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (DCM) (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53). As such, this alteration is classified as likely pathogenic. |
| Baylor Genetics | RCV003333218 | SCV004041442 | likely pathogenic | Dilated cardiomyopathy 1G | 2023-04-07 | criteria provided, single submitter | clinical testing |